View in EDS PDF Full Text

Antiangiogenic treatment with endostatin inhibits progression of AML in vivo.

Saved in:
Bibliographic Details
Title: Antiangiogenic treatment with endostatin inhibits progression of AML in vivo.
Authors: Schuch, G.1 schuch@uke.uni-hamburg.de, Oliveira-Ferrer, L.2, Loges, S.1, Laack, E.1, Bokemeyer, C.1, Hossfeld, D. K.1, Fiedler, W.1, Ergun, S.2
Source: Leukemia (08876924). Aug2005, Vol. 19 Issue 8, p1312-1317. 6p.
Database: Academic Search Ultimate
Description
ISSN:08876924
DOI:10.1038/sj.leu.2403824